BWXT Medical submits Tc-99m generator application to FDA

September 14, 2022, 3:02PMNuclear News

BWXT Medical has submitted a new drug application to the U.S. Food and Drug Administration to request approval of its technetium-99m generator for medical imaging. A daughter isotope of molybdenum-99, Tc-99m is used in more than 40 million diagnostic procedures annually. BWXT Medical is a subsidiary of Lynchburg, Va.-based BWX Technologies.

To continue reading, log in or create a free account!

Related Articles

Using nuclear science to combat food fraud

August 21, 2024, 7:00AMNuclear News

The adulterating of food products for financial gain, either through dilution, substitution, mislabeling, or other action, has become a lucrative industry. And because food fraud is designed...